ClinicalTrials.Veeva

Menu

Impact of the Lab-score on Antibiotic Prescription Rate in Children With Fever Without Source

University Hospitals (UH) logo

University Hospitals (UH)

Status

Completed

Conditions

Fever Without Source

Treatments

Biological: Allocation to the control group
Biological: Allocation to the Lab-score group

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02179398
09-162 (MatPed 09-032)

Details and patient eligibility

About

Detecting serious bacterial infections (SBI) in children presenting to the Pediatric Emergency Department (PED) with fever without source (FWS) is a frequent diagnostic challenge. The recently described Lab-score, based on the combined determination of Procalcitonin, C-Reactive Protein (CRP) and urine dipstick results, has been shown an accurate tool for SBI prediction on retrospective cohorts. The investigators aimed to assess the usefulness of the Lab-score in safely decreasing unnecessary antibiotic prescriptions in children with FWS, and to prospectively determine the diagnostic characteristics of the Lab-score compared to other classically used SBI biomarkers (white blood cell (WBC) count, band count and CRP).

Enrollment

278 patients

Sex

All

Ages

7 days to 3 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • children aged 7 days to 3 years old
  • fever without source ≥ 100.4°F (≥ 38.0°C)

Exclusion criteria

  • antibiotics received in the previous 48 hours
  • underlying congenital or acquired immunodeficiency syndrome
  • fever for more than 7 days at presentation

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

278 participants in 2 patient groups

Lab-score group
Experimental group
Description:
Patients assessed through the Lab-score determination only: Lab-score ≥3 used as the sole marker for the detection of serious bacterial infection. (WBC and band counts blinded to the physician in charge of the patient)
Treatment:
Biological: Allocation to the Lab-score group
Control group
Active Comparator group
Description:
Patients assessed through the following classically admitted biomarkers for the detection of serious bacterial infection: WBC count, band count and CRP determination. (PCT and thus Lab-score blinded to the physician in charge of the patient).
Treatment:
Biological: Allocation to the control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems